Implantation or Injectable Dosage Form New Animal Drugs; Enrofloxacin
other · Food and Drug Administration · Rule · Published 2008-04-02 · Effective 2008-04-02 · 73 FR 17890
Document
Document number
E8-6706
Federal Register citation
73 FR 17890
CFR reference
21 CFR 522
Type
Rule
Action
Final rule.
Category
other
Sub-agency
Food and Drug Administration
Publication date
2008-04-02
Effective date
2008-04-02
Abstract
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Bayer HealthCare, LLC. The supplemental NADA provides for the use of enrofloxacin injectable solution in female dairy cattle less than 20 months of age.